MiR-203a-3p loaded vesicles from stem cells protect against BPD damage

Bronchopulmonary dysplasia (BPD) is a serious lung disease that affects premature infants, often caused by oxygen-induced injury and inflammation in developing lungs. Researchers from Sungkyunkwan University have been exploring how tiny particles called extracellular vesicles (EVs) could help protect fragile newborn lungs.

These vesicles, released by mesenchymal stem cells (MSCs), act as natural messengers by carrying proteins, lipids, and genetic material like microRNAs. The team discovered that a particular microRNA, called miR-203a-3p, inside these vesicles plays a vital role. It helps reduce cell death and calm inflammation, both of which are major problems in BPD.

Schematic diagram of the action mechanism by which miR-203a-3p in MSC-derived EV suppresses apoptotic cell death and inflammation

MiR-203a-3p in MSC-derived EVs inhibits H₂O₂-induced cell death by targeting ID4 and suppresses LPS-induced expression of inflammatory cytokines by targeting Myd88. Our findings demonstrate that miR-203a-3p is a major player in the therapeutic potential of MSC-derived EVs for bronchopulmonary dysplasia. Details are described in the main text

When the researchers boosted levels of miR-203a-3p in EVs, the vesicles became even more effective at protecting lung cells. This suggests that MSC-derived EVs enriched with miR-203a-3p may one day be developed into a therapy to help premature babies breathe more easily and recover from early lung injury.